Grants and Contributions:
Title:
COVID-19 Response: AutoDimer IVD Assay Development
Agreement Number:
949161
Agreement Value:
$50,000.00
Agreement Date:
Apr 20, 2020 - Jun 30, 2021
Description:
This project intends to develop an automated immunoturbidometric assay for the quantitative measurement of D-Dimer. D-Dimer is a cross-linked fibrinogen degradation product.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Windsor, Nova Scotia, CA B0N 2T0
Reference Number:
172-2020-2021-Q1-949161
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
896490125
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 124 days.
Amendment Date
Dec 2, 2020
Recipient's Operating Name:
BioMedica Diagnostics Inc
Recipient's Legal Name:
BioMedica Diagnostics Inc.
Federal Riding Name:
Kings--Hants
Federal Riding Number:
12007
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
325410
Amendments: